Long-Term Pharmacological Management of Reduced Ejection Fraction Following Acute Myocardial Infarction: Current Status and Future Prospects-Reference-Cited by-同舟云学术

Long-Term Pharmacological Management of Reduced Ejection Fraction Following Acute Myocardial Infarction: Current Status and Future Prospects

Published:2021-11 Issue: Volume:Volume 14 Page:7797-7805
ISSN:1178-7074
Container-title:International Journal of General Medicine
language:en
Short-container-title:IJGM

Author:

Abel Alexandra AI,Clark Andrew L

Publisher

Informa UK Limited

Subject

General Medicine

Reference58 articles.

1. The timing of development and subsequent clinical course of heart failure after a myocardial infarction

2. Importance of Congestive Heart Failure and Interaction of Congestive Heart Failure and Left Ventricular Systolic Function on Prognosis in Patients With Acute Myocardial Infarction

3. National Institute for Health and Clinical Excellence NG185 – acute Coronary Syndromes. London: NICE; 2020. Available from: nice.org.uk/guidance/ng185. Accessed July 1, 2021.

4. beta Blockade after myocardial infarction: systematic review and meta regression analysis

5. Are beta-blockers effective in patients who develop heart failure soon after myocardial infarction? A meta-regression analysis of randomised trials

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protective Effect of Combined Metoprolol and Atractylenolide I in Rats with Acute Myocardial Infarction via Modulation of the SIRT3/β-CATENIN/PPAR-γ Signaling Pathway;Brazilian Journal of Pharmaceutical Sciences;2023

2. A systematic review and meta-analysis of sacubitril-valsartan in the treatment of ventricular remodeling in patients with heart failure after acute myocardial infarction;Frontiers in Cardiovascular Medicine;2022-10-11